glp 1 mash approval CDSCO Clears Wegovy for — India's First GLP-1 for Liver Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on FDA Approves Wegovy for MASH

This allows us to adjust your plan based on real-time data and your unique needs

liraglutide), SUSTAIN-6 (Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes

Explore the available testing options, follow the preparation instructions for each test, and review results with the healthcare provider managing your medication

GLP-1 Pill Doesnt Lead to as Much Weight Loss as Injectable Drugs Tan says the weight loss seen so far with orforglipron isnt as dramatic as that achieved with injected GLP-1 drugs

1F) (overall P value = 0.3100, two-way ANOVA with repeated measures)